Search

Your selection

Clear all

Filter by content type

Filter by content year

News

Vaxart, Inc. Announces Management Change

January 16, 2024 - … Chief Executive Officer, and Director on Vaxart’s Board of Directors. Michael J. Finney , Ph.D., the Chair of Vaxart’s Board of Directors, has assumed the role of Interim Chief … successor. Dr. Finney has served as a member of the Board of Directors since February 2018 and Chair of the Board …
News

Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director

March 6, 2024 - … Michael J. Finney , Ph.D. to Continue as Chairman of the Board of Directors SOUTH SAN FRANCISCO, Calif. , March 06, … President and Chief Executive Officer and a member of the Board of Directors, effective as of March 18, 2024 . Mr. Lo … Officer and will continue to serve as Chair of the Board of Directors. “I am delighted to welcome Steve to …
News

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 23, 2024 - … that on May 17, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering … that on May 17, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering … that on May 17, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering …
News

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 30, 2024 - … on August 26, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering … on August 26, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering … on August 26, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering …
News

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 19, 2024 - … on November 15, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering … on November 15, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering … on November 15, 2024 , the Compensation Committee of the Board of Directors granted inducement equity awards covering …
News

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 20, 2024 - … today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the … President and Chief Executive Officer and a member of the Board of Directors. The awards made to Mr. Lo are as follows: … today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the …
News

Vaxart Provides Business Update and Reports Full Year 2023 Financial Results

March 14, 2024 - … Steven Lo appointed President, Chief Executive Officer and Board Member Conference call today at 4:30 p.m. ET SOUTH SAN … President and Chief Executive Officer and a member of the Board of Directors , effective March 18, 2024 . Dr. Finney will continue to serve as Chair of the Board of Directors. Financial Results for the Full Year …
News

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

December 2, 2024 - … mRNA vaccine.” An independent Data and Safety Monitoring Board (DSMB) and the U.S. Food and Drug Administration (FDA) … mRNA vaccine.” An independent Data and Safety Monitoring Board (DSMB) and the U.S. Food and Drug Administration (FDA) … mRNA vaccine.” An independent Data and Safety Monitoring Board (DSMB) and the U.S. Food and Drug Administration (FDA) …
News

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

September 30, 2024 - … comparator. Once an independent Data and Safety Monitoring Board (DSMB) and FDA review the 30-day safety data of the 400 … comparator. Once an independent Data and Safety Monitoring Board (DSMB) and FDA review the 30-day safety data of the 400 … comparator. Once an independent Data and Safety Monitoring Board (DSMB) and FDA review the 30-day safety data of the 400 …
News

Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

June 13, 2024 - … An independent Data and Safety Monitoring Board (DSMB) will review safety data of the participants. … An independent Data and Safety Monitoring Board (DSMB) will review safety data of the participants. … An independent Data and Safety Monitoring Board (DSMB) will review safety data of the participants. …
Scroll to Top